|
TRDMT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.239590E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.883100E-03 |
| Normal-vs-Stage2 |
1.796440E-01 |
| Normal-vs-Stage3 |
7.81180000020143E-07 |
| Normal-vs-Stage4 |
7.75559999555142E-08 |
| Stage1-vs-Stage2 |
7.414600E-01 |
| Stage1-vs-Stage3 |
2.777800E-03 |
| Stage1-vs-Stage4 |
1.046490E-04 |
| Stage2-vs-Stage3 |
5.962400E-02 |
| Stage2-vs-Stage4 |
1.881730E-02 |
| Stage3-vs-Stage4 |
3.847600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.372100E-04 |
| Normal-vs-AfricanAmerican |
8.18160000000123E-05 |
| Normal-vs-Asian |
1.718640E-01 |
| Caucasian-vs-AfricanAmerican |
1.330210E-01 |
| Caucasian-vs-Asian |
9.579400E-01 |
| AfricanAmerican-vs-Asian |
5.654600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92339999999636E-05 |
| Normal-vs-Female |
2.578000E-03 |
| Male-vs-Female |
4.346600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.582400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.803100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.6648000000008E-05 |
| Normal-vs-Age(81-100Yrs) |
5.881700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.563800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.716800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.029200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.974560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.791400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.275400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.542800E-01 |
| Normal-vs-Grade 2 |
1.286560E-01 |
| Normal-vs-Grade 3 |
2.30509999976647E-07 |
| Normal-vs-Grade 4 |
2.40419995023444E-09 |
| Grade 1-vs-Grade 2 |
2.436400E-01 |
| Grade 1-vs-Grade 3 |
6.18909999999806E-05 |
| Grade 1-vs-Grade 4 |
1.77719999999715E-05 |
| Grade 2-vs-Grade 3 |
5.13629999976395E-07 |
| Grade 2-vs-Grade 4 |
1.59459999649059E-08 |
| Grade 3-vs-Grade 4 |
2.238500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.582000E-01 |
| Normal-vs-ccB subtype |
2.78499999950554E-07 |
| ccA subtype-vs-ccB subtype |
1.91980000008307E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.996700E-03 |
| Normal-vs-N1 |
4.184700E-04 |
| N0-vs-N1 |
4.474200E-02 |
|
|
